Is Liaoning Chengda Biotechnology Co Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Liaoning Chengda Biotechnology Co Ltd (688739.SS) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Liaoning Chengda Biotechnology Co Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Liaoning Chengda Biotechnology Co Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Liaoning Chengda Biotechnology Co Ltd?

Muslim investors may consider investing in Liaoning Chengda Biotechnology Co Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Liaoning Chengda Biotechnology Co Ltd classified as NOT COVERED?

Musaffa determines the Shariah status of Liaoning Chengda Biotechnology Co Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Liaoning Chengda Biotechnology Co Ltd updated?

The Shariah compliance status of Liaoning Chengda Biotechnology Co Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Liaoning Chengda Biotechnology Co Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Liaoning Chengda Biotechnology Co Ltd?

You can check the latest Shariah compliance status of Liaoning Chengda Biotechnology Co Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Liaoning Chengda Biotechnology Co Ltd 688739.SS

Last Updated: May 15, 12:00 AM·SSE

Liaoning Chengda Biotechnology Co Ltd. Stock Analysis 688739.SS

China Health Care Small Cap

Liaoning Chengda Biotechnology Co., Ltd. engages in the research, development, production and sale of human vaccines. The company is headquartered in Shenyang, Liaoning and currently employs 1,781 full-time employees. The company went IPO on 2021-10-28. The firm's products include rabies vaccine for human use and inactivated Japanese encephalitis vaccine. The firm has completed the construction of bacterial vaccine technology platform, viral vaccine technology platform, multi-component multivalent vaccine technology platform and recombinant protein vaccine technology platform. The firm mainly conducts its businesses in the domestic and foreign markets.

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.

I accept the above